Your browser doesn't support javascript.
loading
Mode of action of trabectedin in myxoid liposarcomas.
Di Giandomenico, S; Frapolli, R; Bello, E; Uboldi, S; Licandro, S A; Marchini, S; Beltrame, L; Brich, S; Mauro, V; Tamborini, E; Pilotti, S; Casali, P G; Grosso, F; Sanfilippo, R; Gronchi, A; Mantovani, R; Gatta, R; Galmarini, C M; Sousa-Faro, J M F; D'Incalci, M.
Afiliação
  • Di Giandomenico S; Department of Oncology, IRCCS-Istituto di Ricerche Farmacologiche 'Mario Negri', Milan, Italy.
  • Frapolli R; Department of Oncology, IRCCS-Istituto di Ricerche Farmacologiche 'Mario Negri', Milan, Italy.
  • Bello E; Department of Oncology, IRCCS-Istituto di Ricerche Farmacologiche 'Mario Negri', Milan, Italy.
  • Uboldi S; Department of Oncology, IRCCS-Istituto di Ricerche Farmacologiche 'Mario Negri', Milan, Italy.
  • Licandro SA; Department of Oncology, IRCCS-Istituto di Ricerche Farmacologiche 'Mario Negri', Milan, Italy.
  • Marchini S; Department of Oncology, IRCCS-Istituto di Ricerche Farmacologiche 'Mario Negri', Milan, Italy.
  • Beltrame L; Department of Oncology, IRCCS-Istituto di Ricerche Farmacologiche 'Mario Negri', Milan, Italy.
  • Brich S; Department of Pathology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Mauro V; Department of Pathology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Tamborini E; Department of Pathology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Pilotti S; Department of Pathology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Casali PG; Adult Sarcoma Medical Treatment Unit, Cancer Medicine Department, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Grosso F; Department of Oncology, SS Antonio e Biagio General Hospital, Alessandria, Italy.
  • Sanfilippo R; Adult Sarcoma Medical Treatment Unit, Cancer Medicine Department, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Gronchi A; Department of Surgery, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Mantovani R; Dipartimento di Bioscienze, Università degli Studi di Milano, Milan, Italy.
  • Gatta R; Dipartimento di Bioscienze, Università degli Studi di Milano, Milan, Italy.
  • Galmarini CM; PharmaMar S.A., Madrid, Spain.
  • Sousa-Faro JM; PharmaMar S.A., Madrid, Spain.
  • D'Incalci M; Department of Oncology, IRCCS-Istituto di Ricerche Farmacologiche 'Mario Negri', Milan, Italy.
Oncogene ; 33(44): 5201-10, 2014 Oct 30.
Article em En | MEDLINE | ID: mdl-24213580
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas de Fusão Oncogênica / Lipossarcoma Mixoide / Antineoplásicos Alquilantes / Proteína FUS de Ligação a RNA / Tetra-Hidroisoquinolinas / Dioxóis / Fator de Transcrição CHOP Tipo de estudo: Prognostic_studies Limite: Adult / Animals / Female / Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas de Fusão Oncogênica / Lipossarcoma Mixoide / Antineoplásicos Alquilantes / Proteína FUS de Ligação a RNA / Tetra-Hidroisoquinolinas / Dioxóis / Fator de Transcrição CHOP Tipo de estudo: Prognostic_studies Limite: Adult / Animals / Female / Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article